| Cell line name |
UROtsa/F35 |
|---|
| Accession |
CVCL_M721 |
|---|
| Resource Identification Initiative |
To cite this cell line use: UROtsa/F35 (RRID:CVCL_M721) |
|---|
| Comments |
Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=23691160).
Population: Caucasian; Swedish.
Derived from sampling site: Urinary bladder. |
|---|
| Sequence variations |
- Mutation; HGNC; 5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
- Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
- Mutation; HGNC; 11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
|
|---|
| Disease |
Bladder carcinoma (NCIt: C4912) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Hierarchy |
Parent: CVCL_0554 (T24) |
|---|
| Sex of cell |
Female |
|---|
| Age at sampling |
82Y |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=16102566; DOI=10.1016/j.taap.2004.12.007
Drobna Z., Waters S.B., Devesa V., Harmon A.W., Thomas D.J., Styblo M.
Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase.
Toxicol. Appl. Pharmacol. 207:147-159(2005) PubMed=23691160; DOI=10.1371/journal.pone.0064139
Johnen G., Rozynek P., von der Gathen Y., Bryk O., Zdrenka R., Johannes C., Weber D.G., Igwilo-Okuefuna O.B., Raiko I., Hippler J., Bruning T., Dopp E.
Cross-contamination of a UROtsa stock with T24 cells -- molecular comparison of different cell lines and stocks.
PLoS ONE 8:E64139-E64139(2013) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q54991845
|
|---|
| Entry history |
|---|
| Entry creation | 05-Nov-2013 |
|---|
| Last entry update | 21-Mar-2023 |
|---|
| Version number | 15 |
|---|
